Search

Veterinary Oncology Market

Veterinary Oncology Market Size by Animal Type (Companion Animal, Canine, Equine, Feline and Livestock Animal), Therapy Type (Surgery, Radiology, Chemotherapy), Cancer Type, Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2024 to 2033

Base Year: 2023 Historical Data: 2020-22
  • Report ID: TBI-12587
  • Published Date: Oct, 2024
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Global veterinary oncology market is anticipated to reach USD 1,161.83 million by 2033, at a CAGR of 12% from 2024 to 2033. Growing cancer pervasiveness in the pet population and rising adoption of veterinary cancer therapy as a method of treatment propel market growth. Animal healthcare expenditure in developed economies due to increased willingness to spend on pet healthcare by owners and government initiatives for veterinary cancer treatment are the key factors driving the growth of the market. Enhanced diagnostic and monitoring tools can help detect cancer early, allowing better results to be found and thus driving the growth of the Veterinary Oncology market. Partnerships between veterinary clinics and pharmaceutical companies can be formed further to boost the growth of the global Veterinary Oncology market.

Market Overview:

Cancer is an uncontrolled, abnormal growth of cells. It's present both in humans and in animals. There are many different types of cancer present in animals, with symptoms quite close to that seen in humans (e.g. abnormal swelling, unexpected weight loss, lethargy/willingness to exercise, etc). Some of the common cancer types in animals include canine lymphoma, osteosarcoma (OSA), mast cell cancer, melanoma and multiple myeloma. Lymphoma (lymphosarcoma) is a form of cancer in animals characterized by the development of malignant lymphocytes in solid organs like the bone marrow, lymph nodes, spleen and liver. The disease may also exist in the body, gastrointestinal tract and skin. Osteosarcoma is a bone malignant tumour. This disease has the same appearance in humans as juvenile osteosarcoma. They are tumors that occur from an abnormal development of cells that make and break the bone (called osteoblasts and osteoclasts, respectively). The long bones (legs and arms) are more commonly affected, while bones such as the hips, jaw, or pelvis can often be impacted. Mast cell tumor (MCT) is a cancer of a type of blood cell which is usually involved in the response of the body to allergens and inflammation. MCT is the most prevalent skin tumor in dogs; other parts of the body can also be affected, including spleen, liver, gastrointestinal tract, and bone marrow. As in humans, in dogs, malignant melanoma is a form of skin cancer that affects melanocytes, the pigmented cells. The dogs also develop benign tumors which are termed melanocytomas in pigmented cells that do not metastasize. Those tumors are located on the hair-bearing areas of the dog's body.

Veterinary oncology is a veterinary medicine subspecialty which deals with the diagnosis and treatment of cancer in animals. For pet animals, cancer is a significant cause of death. Numerous treatment modalities are available to veterinary patients, and these modalities are gradually being applied in combination to enhance effectiveness. As standalone therapies, the generally used modalities include chemotherapy, combination therapy, immunotherapy and targeted therapy. Veterinary Oncology helps prevent many problems caused by cancer, such as pain, nausea, and discomfort, and provides quality life to pets. Treatment plans can also be changed according to the pet's condition.

Veterinary Oncology Market Size

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers
  • Growing research and development

Increasing research and development in veterinary oncology is a significant driver for the market as recent studies have traced cancer cell ancestry of canine species. It is expected to give the veterinary oncology market a significant impetus for growth.

Restraints:
  • Increasing concerns about side-effects

In the global veterinary oncology market, growing concerns about side effects and the reduced lifespan of pets remain a concern. Changes in appetite, diarrhoea, lethargy, allergic reactions and other side effects are common from the treatment.

Opportunities:
  • Rising spending on animal healthcare

Increasing animal healthcare spending in developed economies as a consequence of increasing willingness to spend on pet healthcare by owners and government programs for veterinary cancer treatment are the key drivers of market growth.

Challenges:
  • Higher cost associated with the therapies

Higher costs associated with chemotherapy, immunotherapy, and targeted therapies are significant factors limiting the growth of the market for veterinary oncology.

Segmentation Analysis:

The global veterinary oncology market has been segmented based on animal type, therapy type, cancer type and regions.

  • The animal type segment is divided into companion animal, equine, canine, feline and livestock animal. The canine segment held the largest market share of around 26.5% in 2023 owing to the elevated cancer rate and improved life expectancy of canine populations. Moreover, with a growing number of clinical trials on canine as a biological model, the increasing incidence of cancer in this population has also engaged researchers to conduct comparative veterinary oncology treatments.
  • The therapy type segment includes surgery, radiology, chemotherapy. The chemotherapy segment held the largest market share of around 34.5% in 2023 because the number of chemotherapeutic procedures adopted by the surgeons is increasing due to their numerous advantages.
  • The cancer type segment includes lymphoma, osteosarcoma (OSA), mast cell cancer, melanoma and multiple myeloma. The lymphoma segment held the largest market share of around 26.8% in 2023 because of the growing numbers of pet populations affected by the disease, especially canine ones.
Regional Segmentation Analysis:

The regions evaluated for the veterinary oncology market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. The North America region emerged as the largest market for the veterinary oncology, with a 30.4% share of market revenue in 2023. Moreover, over the forecast period North America is expected to continue its dominance in the market.

North America Veterinary Oncology Market Share in 2023 - 30.4%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • Increasing emphasis on pet health, the emergence of a growing number of pet drug manufacturers and the rapid adoption of innovative pet care medications are main factors contributing to market growth. Moreover, growing number of government funding for pet oncology treatment in this region and the presence of market giants in the oncology market are also driving the market growth.
  • With the presence of regulatory authorities focused on scientific advancement in veterinary and comparative oncology, the Europe sector is projected to be the second-largest region in terms of revenues over the forecast period. These authorities collaborate with major industry leaders to focus on developing unparalleled pet oncology treatment solutions.
Competitive Analysis:

In May 2016, Zenoaq, a significant animal health company headquartered in Japan, and Nexvet Biopharma, a veterinary biology manufacturer, have revealed their research and development partnership, creating monoclonal antibodies (mAbs) that bind and effectively inhibit the immuno-oncology target programmed cell death protein 1 (PD-1).

  • AB Science
  • Accuray Incorporated
  • AdvaVet, Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco
  • Karyopharm Therapeutics, Inc.
  • Karyopharm Therapeutics, Inc.
  • Morphogenesis, Inc.
  • Nippon Zenyaku Kogyo Co., Ltd.
  • One Health
  • PetCure Oncology
  • Regeneus Ltd.
  • Rhizen Pharmaceutical SA
  • Varian Medical System, Inc.
  • VetDC
  • Zenoaq
  • Zoetis Inc.
Key Target Audience
  • Hospitals
  • Research and Consulting Firms
  • Veterinary Oncologists
  • Pet Owners
  • Research Laboratories and Institutes

Report Description

  • Global Veterinary Oncology Market, Industry Analysis, Trends, Analysis and Forecast, 2024 to 2033 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2023 is considered as the base year of the report. 2020 to 2022 are considered as the historic years and 2024 to 2033 are the forecast years. The global veterinary oncology market is based on revenue (USD billion). The report incorporates the market study on the basis of revenue. The study covers the market share revenue/market share for each of the segments, regions and countries catering to global Veterinary Oncology market. The regions evaluated for the Veterinary Oncology market are Europe, Asia Pacific, North America, South America and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts all across the globe. The research report also delivers an outline of the attractiveness of veterinary oncology and regions which are deduced and formulated on the basis of their growth rate (CAGR), market size, and attractiveness by analyzing the present and future prospects to fathom market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to global veterinary oncology market.  This offers vital and in depth insights in order to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global veterinary oncology market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development & innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario. 
  • The report provides an elaborative assessment of the porter’s five forces analysis coupled with SWOT analysis so as to provide business related data and information’s. Porter’s five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company growth and development in order to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which acts as a key potential for the investors. 
  • Potential growth prospects along with the penetration rate analysis of the products (market related i.e., global veterinary oncology market) is covered in order to comprehend the adoption rate and evaluate the market size.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the veterinary oncology market was valued at USD 374.08 million in 2023 and is anticipated to reach USD 1,161.83 million by 2033.

Global veterinary oncology market is growing at a CAGR of 12% during the forecast period 2024-2033.

The global veterinary oncology market has been segmented based on animal type, therapy type, cancer type and regions. The canine segment held the largest market share in 2023. The chemotherapy segment, also held the largest market share in 2023.

The North America region emerged as the largest market for the veterinary oncology.

Growing research and development is the key driving factor for the veterinary oncology market.

Increasing concerns about side-effects could hamper the market growth.

Rising spending on animal healthcare will provide huge opportunities to the market.

Key players are AB Science, Accuray Incorporated, AdvaVet, Inc., BoehringerIngelheim International GmbH, Elanco, Karyopharm Therapeutics, Inc.

Get Your Report Customized

  • Further segmentation of the market on the basis of type, application, end use, product, technology, method, process and any other segment depending on the market
  • Segmentation on the basis of any specific country or region
  • Any segment can be classified on the basis of application
  • Application segment can be further divided on the basis of companies
  • The companies profiled are not limited, we can incorporate additional companies of your choice
  • We can split the company market share on the basis of product, application and region
  • Report can be prepared for any specific country/region/segment
  • Customers can be added on the basis of regions and countries
Request for Customization

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Animal Type
          4.3.2. Market Attractiveness Analysis By Therapy Type
          4.3.3. Market Attractiveness Analysis By Cancer Type
          4.3.4. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Growing Research and Development
    5.3. Restraints
          5.3.1. Increasing Concerns About Side-Effects
    5.4. Opportunities
          5.4.1. Rising Spending on Animal Healthcare
    5.5. Challenges
          5.5.1. Higher Cost Associated With The Therapies

6. Global Veterinary Oncology Market Analysis and Forecast, By Animal Type
    6.1. Segment Overview
    6.2. Companion Animal
    6.3. Equine
    6.4. Canine
    6.5. Feline
    6.6. Livestock Animal

7. Global Veterinary Oncology Market Analysis and Forecast, By Therapy Type
    7.1. Segment Overview
    7.2. Surgery
    7.3. Radiology
    7.4. Chemotherapy

8. Global Veterinary Oncology Market Analysis and Forecast, By Cancer Type
    8.1. Segment Overview
    8.2. Lymphoma
    8.3. Osteosarcoma (OSA)
    8.4. Mast Cell Cancer
    8.5. Melanoma
    8.6. Multiple Myeloma

9. Global Veterinary Oncology Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Veterinary Oncology Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in Global Veterinary Oncology Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. AB Science
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Accuray Incorporated
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. AdvaVet, Inc.
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. BoehringerIngelheim International GmbH
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Elanco
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. Karyopharm Therapeutics, Inc.
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Morphogenesis, Inc.
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Nippon Zenyaku Kogyo Co., Ltd.
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. One Health
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. PetCure Oncology
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
    11.11. Regeneus Ltd.
          11.11.1. Business Overview
          11.11.2. Company Snapshot
          11.11.3. Company Market Share Analysis
          11.11.4. Company Product Portfolio
          11.11.5. Recent Developments
          11.11.6. SWOT Analysis
    11.12. Rhizen Pharmaceutical SA
          11.12.1. Business Overview
          11.12.2. Company Snapshot
          11.12.3. Company Market Share Analysis
          11.12.4. Company Product Portfolio
          11.12.5. Recent Developments
          11.12.6. SWOT Analysis
    11.13. Varian Medical System, Inc.
          11.13.1. Business Overview
          11.13.2. Company Snapshot
          11.13.3. Company Market Share Analysis
          11.13.4. Company Product Portfolio
          11.13.5. Recent Developments
          11.13.6. SWOT Analysis
    11.14. VetDC
          11.14.1. Business Overview
          11.14.2. Company Snapshot
          11.14.3. Company Market Share Analysis
          11.14.4. Company Product Portfolio
          11.14.5. Recent Developments
          11.14.6. SWOT Analysis
    11.15. Zenoaq
          11.15.1. Business Overview
          11.15.2. Company Snapshot
          11.15.3. Company Market Share Analysis
          11.15.4. Company Product Portfolio
          11.15.5. Recent Developments
          11.15.6. SWOT Analysis
    11.16. Zoetis Inc.
          11.16.1. Business Overview
          11.16.2. Company Snapshot
          11.16.3. Company Market Share Analysis
          11.16.4. Company Product Portfolio
          11.16.5. Recent Developments
          11.16.6. SWOT Analysis

List of Table

1. Global Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

2. Global Companion Animal In Veterinary Oncology Market, By Region, 2020–2033(USD Million)

3. Global Equine In Veterinary Oncology Market, By Region, 2020–2033(USD Million)

4. Global Canine In Veterinary Oncology Market, By Region, 2020–2033(USD Million)

5. Global Feline Veterinary Oncology Market, By Region, 2020–2033(USD Million)

6. Global Livestock Animal Veterinary Oncology Market, By Region, 2020–2033(USD Million)

7. Global Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

8. Global Surgery, Veterinary Oncology Market, By Region, 2020–2033(USD Million)

9. Global Radiology, Veterinary Oncology Market, By Region, 2020–2033(USD Million)

10. Global Chemotherapy, Veterinary Oncology Market, By Region, 2020–2033(USD Million)

11. Global Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

12. Global Lymphoma, Veterinary Oncology Market, By Region, 2020–2033(USD Million)

13. Global Osteosarcoma (OSA), Veterinary Oncology Market, By Region, 2020–2033 (USD Million)

14. Global Mast Cell Cancer, Veterinary Oncology Market, By Region, 2020–2033 (USD Million)

15. Global Melanoma, Veterinary Oncology Market, By Region, 2020–2033 (USD Million)

16. Global Multiple Myeloma, Veterinary Oncology Market, By Region, 2020–2033 (USD Million)

17. Global Veterinary Oncology Market, By Region, 2020–2033(USD Million)

18. Global Veterinary Oncology Market, By North America, 2020–2033(USD Million)

19. North America Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

20. North America Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

21. North America Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

22. U.S. Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

23. U.S. Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

24. U.S. Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

25. Canada Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

26. Canada Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

27. Canada Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

28. Mexico Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

29. Mexico Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

30. Mexico Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

31. Europe Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

32. Europe Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

33. Europe Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

34. Germany Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

35. Germany Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

36. Germany Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

37. France Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

38. France Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

39. France Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

40. U.K. Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

41. U.K. Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

42. U.K. Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

43. Italy Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

44. Italy Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

45. Italy Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

46. Spain Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

47. Spain Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

48. Spain Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

49. Asia Pacific Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

50. Asia Pacific Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

51. Asia Pacific Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

52. Japan Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

53. Japan Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

54. Japan Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

55. China Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

56. China Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

57. China Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

58. India Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

59. India Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

60. India Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

61. South America Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

62. South America Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

63. South America Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

64. Brazil Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

65. Brazil Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

66. Brazil Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

67. Middle East and Africa Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

68. Middle East and Africa Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

69. Middle East Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

70. UAE Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

71. UAE Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

72. UAE Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

73. South Africa Veterinary Oncology Market, By Animal Type, 2020–2033(USD Million)

74. South Africa Veterinary Oncology Market, By Therapy Type, 2020–2033(USD Million)

75. South Africa Veterinary Oncology Market, By Cancer Type, 2020–2033(USD Million)

List of Figures 

1. Global Veterinary Oncology Market Segmentation

2. Veterinary Oncology Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Veterinary Oncology Market Attractiveness Analysis By Animal Type

9. Global Veterinary Oncology Market Attractiveness Analysis By Therapy Type

10. Global Veterinary Oncology Market Attractiveness Analysis By Cancer Type

11. Global Veterinary Oncology Market Attractiveness Analysis By Region

12. Global Veterinary Oncology Market: Dynamics

13. Global Veterinary Oncology Market Share By Animal Type (2023 & 2033)

14. Global Veterinary Oncology Market Share By Therapy Type (2023 & 2033)

15. Global Veterinary Oncology Market Share By Cancer Type (2023 & 2033)

16. Global Veterinary Oncology Market Share by Regions (2023 & 2033)

17. Global Veterinary Oncology Market Share by Company (2023)

This study forecasts revenue growth at global, regional, and country levels from 2020 to 2033. The Brainy Insights has segmented the global veterinary oncology market on the basis of below mentioned segments:

Global Veterinary Oncology Market by Animal Type:

  • Companion Animal
  • Equine
  • Canine
  • Feline
  • Livestock Animal

Global Veterinary Oncology Market by Therapy Type:

  • Surgery
  • Radiology
  • Chemotherapy

Global Veterinary Oncology Market by Cancer Type:

  • Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma

Global Veterinary Oncology Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Ask for customization Request Sample Speak to analyst Inquire before buying

Flexible Purchase Options

  • Chapters of your choice
  • Quantitative Information for Historical & Forecasted Data
  • Regional/Country Level Reports
Request for Special Pricing

Get in touch with us

+1-315-215-1633

sales@thebrainyinsights.com

Our Clients

Why choose us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date